The Director-General of the National Agency for Food Drugs and Administration Control (NAFDAC), Prof. Mojisola Adeyeye has said her agency has received about four submissions as a potential cure for COVID-19.
The DG explained the submission was made after the agency called for expression of interest for the COVID-19 related medicines from researchers and practitioners.
The NAFDAC DG, who was a guest on a morning television show monitored on Tuesday by The Nation, said the four applications submitted would undergo due diligence.
The DG also said instead of spending huge sums of money to get the COVID organic from Madagascar, such monies should be spent on herbal remedies produced in Nigeria.
Giving an update on the number of applications received so far by the agency, she said: “I made a call for people to submit their application and I believe we have about three or four now and we are going to expedite the processing because it takes a while for us to go through the laboratory testing and what not but I have already given the directive to expedite.
“So, where we are right now is just to make sure that the information submitted is okay and by the end of the week, we may be sending these samples to the lab after we must have gone to inspect the site where the products are made because we don’t want a product that somebody will take and the person will start vomiting.
“So, we will go and inspect the site to make sure that whatever sample we are going to get must have been prepared in an environment that will not make the drug to compromise the health of the user.”
On the criteria that a remedy must meet before it is presented to NAFDAC as a possible cure or drug, she said: “If somebody says he or she has a remedy for COVID, first of all, we want to know the history of the plant or the family the plant belongs to, background information on the botanical characteristics of the plant, we will also want to know whether the plant has been used for anything before because sometimes, we use one plant for several diseases and the usage will be different for a particular disease.